Cited by 7,439Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionEconomic and Financial Impacts of Cancer

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Cancer Statistics, 2007

Open access

Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, M. J.·2007·CA: A Cancer Journal for Clinicians

DOI 10.3322/canjclin.57.1.43

Open this paper in CoChat — free account

Abstract

Each year, the American Cancer Society (ACS) estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. This report considers incidence data through 2003 and mortality data through 2004. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,444,920 new cancer cases and 559,650 deaths for cancers are projected to occur in the United States in 2007. Notable trends in cancer incidence and mortality rates include stabilization of the age-standardized, delay-adjusted incidence rates for all cancers combined in men from 1995 through 2003; a continuing increase in the incidence rate by 0.3% per year in women; and a 13.6% total decrease in age-standardized cancer death rates among men and women combined between 1991 and 2004. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. While the absolute number of cancer deaths decreased for the second consecutive year in the United States (by more than 3,000 from 2003 to 2004) and…

Integrity signals

Registry

Crossref · 10.3322/canjclin.57.1.43

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V. E., Singh, G. K., Cardinez, C. J., Ghafoor, A., & Thun, M. J. (2004) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,796
Self-citation
Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,141
Self-citation
Cancer Statistics for African Americans
Ghafoor, A., Jemal, A., Cokkinides, V. E., Cardinez, C. J., Murray, T., Samuels, A., & Thun, M. J. (2002) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.326 · Cited by 549
Self-citation
Cancer Survival Among US Whites and Minorities
Clegg, L. X., Li, F. P., Hankey, B. F., Chu, K. C., & Edwards, B. K. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.17.1985 · Cited by 535
Survival of Blacks and Whites After a Cancer Diagnosis
Bach, P. B. (2002) · JAMA · doi:10.1001/jama.287.16.2106 · Cited by 514
Trends in Breast Cancer by Race and Ethnicity
Ghafoor, A., Jemal, A., Ward, E., Cokkinides, V. E., Smith, R. A., & Thun, M. J. (2003) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.6.342 · Cited by 450
Self-citation
Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.20.1537 · Cited by 282
A New Method of Estimating United States and State-level Cancer Incidence Counts for the Current Calendar Year
Pickle, L. W., Hao, Y., Jemal, A., Zou, Z., Tiwari, R. C., Ward, E., Hachey, M., Howe, H. L., & Feuer, E. J. (2007) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.30 · Cited by 114
Self-citation
A New Method of Predicting US and State-Level Cancer Mortality Counts for the Current Calendar Year
Tiwari, R. C., Ghosh, K., Jemal, A., Hachey, M., Ward, E., Thun, M. J., & Feuer, E. J. (2004) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.30 · Cited by 67
Self-citation

Show all 10 references

Sorted by citations

Items 201–300 of 1,016

Breast cancer metastasis to the bone: mechanisms of bone loss
Chen, Y., Sosnoski, D. M., & Mastro, A. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2781 · Cited by 283
Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy
Liao, Z. X., Komaki, R. R., Thames, H. D., Liu, H. H., Tucker, S. L., Mohan, R., Martel, M. K., Wei, X., Yang, K., Kim, E. S., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.032 · Cited by 282
Role for sphingosine kinase 1 in colon carcinogenesis
Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A. B., Bielawski, J., Hannun, Y. A., & Obeid, L. M. (2008) · The FASEB Journal · doi:10.1096/fj.08-117572 · Cited by 282
Pathological Upgrading and Up Staging With Immediate Repeat Biopsy in Patients Eligible for Active Surveillance
Berglund, R. K., Masterson, T. A., Vora, K. C., Eggener, S. E., Eastham, J. A., & Guillonneau, B. D. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.07.051 · Cited by 281
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment
Hallek, M. J. (2017) · American Journal of Hematology · doi:10.1002/ajh.24826 · Cited by 296
CXCL8/IL‐8 and CXCL12/SDF‐1α co‐operatively promote invasiveness and angiogenesis in pancreatic cancer
Matsuo, Y., Ochi, N., Sawai, H., Yasuda, A., Takahashi, H., Funahashi, H., Takeyama, H., Tong, Z., & Guha, S. (2008) · International Journal of Cancer · doi:10.1002/ijc.24040 · Cited by 280
Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia
Ahlquist, D. A., Sargent, D. J., Loprinzi, C. L., Levin, T. R., Rex, D. K., Ahnen, D. J., Knigge, K. L., Lance, M. P., Burgart, L. J., Hamilton, S. R., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-7-200810070-00004 · Cited by 280
The effects of physical activity on cortisol and sleep: A systematic review and meta-analysis.
De Nys, L., Anderson, K., Ofosu, E. F., Ryde, G. C., Connelly, J., & Whittaker, A. C. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105843 · Cited by 279
Cancer Cell Membrane-Coated Nanoparticles for Cancer Management
Harris, J. C., Scully, M. A., & Day, E. S. (2019) · Cancers · doi:10.3390/cancers11121836 · Cited by 288
A subpopulation of CD133+ cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy
Zhang, Q., Shi, S., Yen, Y., Brown, J., Ta, J. Q., & Le, A. D. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.010 · Cited by 278
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
Iliopoulou, E. G., Kountourakis, P., Karamouzis, M. V., Doufexis, D., Ardavanis, A. S., Baxevanis, C. N., Rigatos, G. A., Papamichail, M., & Perez, S. A. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0904-3 · Cited by 277
Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma
Kusmartsev, S. A., Eruslanov, E. B., Kübler, H. R., Tseng, T. Y., Sakai, Y., Su, Z. Z., Kaliberov, S. A., Heiser, A., Rosser, C. J., Dahm, P., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.346 · Cited by 280
An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer
Feldmann, G., Fendrich, V., McGovern, K., Bedja, D., Bisht, S., Alvarez, H., Koorstra, J.-B. M., Habbe, N., Karikari, C. A., Mullendore, M. E., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0573 · Cited by 275
Prostate-Specific Antigen and Pain Surrogacy Analysis in Metastatic Hormone-Refractory Prostate Cancer
Armstrong, A. J., Garrett-Mayer, E. S., Yang, Y.-C. O., Carducci, M. A., Tannock, I. F., de Wit, R., & Eisenberger, M. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4769 · Cited by 274
Serous Carcinogenesis in the Fallopian Tube
Jarboe, E. A., Folkins, A. K., Nucci, M. R., Kindelberger, D. W., Drapkin, R., Miron, A., Lee, Y., & Crum, C. P. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31814b191f · Cited by 273
Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors
Smith, J. S., Backes, D. M., Hoots, B., Kurman, R. J., & Pimenta, J. M. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31819bd6e0 · Cited by 273
MicroRNA-137 Targets Microphthalmia-Associated Transcription Factor in Melanoma Cell Lines
Bemis, L., Chen, R., Amato, C. M., Classen, E. H., Robinson, S. E., Coffey, D. G., Erickson, P. F., Shellman, Y. G., & Robinson, W. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2912 · Cited by 277
Cancer stem cells: implications for the progression and treatment of metastatic disease
Croker, A. K., & Allan, A. L. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00211.x · Cited by 274
Active surveillance for early‐stage prostate cancer
Dall’Era, M., Cooperberg, M. R., Chan, J. M., Davies, B. J., Albertsen, P. C., Klotz, L. H., Warlick, C. A., Holmberg, L., Bailey, D. E., Wallace, M. E., et al. (2008) · Cancer · doi:10.1002/cncr.23373 · Cited by 272
Exercise Interventions for Cancer Survivors: A Meta-Analysis of Quality of Life Outcomes
Ferrer, R. A., Huedo-Medina, T. B., Johnson, B. T., Ryan, S. M., & Pescatello, L. S. (2010) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9225-1 · Cited by 282
Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy
Hirsch, F. R., Herbst, R. S., Olsen, C. C., Chansky, K., Crowley, J. J., Kelly, K. L., Franklin, W. A., Bunn, P. A., Varella‐Garcia, M., & Gandara, D. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.0111 · Cited by 273
T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival
Boorjian, S. A., Sheinin, Y. M., Crispen, P. L., Farmer, S. A., Lohse, C. M., Kuntz, S. M., Leibovich, B. C., Kwon, E. D., & Frank, I. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0731 · Cited by 270
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma
Yang, X., Xu, Y., Yu, B., Zhou, J., Qiu, S., Shi, G., Zhang, B.-H., Wu, W., Shi, Y.-H., Wu, B., et al. (2010) · Gut · doi:10.1136/gut.2008.176271 · Cited by 270
Prognostic significance of MMP‐9 and TIMP‐1 serum and tissue expression in breast cancer
Wu, Z., Wu, Q., Yang, J., Hong-qun, W., Ding, X., Yang, F., & Xu, X. (2008) · International Journal of Cancer · doi:10.1002/ijc.23337 · Cited by 269
Use of Video-Assisted Thoracic Surgery for Lobectomy in the Elderly Results in Fewer Complications
Cattaneo, S. M., Park, B. J., Wilton, A. S., Seshan, V., Bains, M. S., Downey, R. J., Flores, R. M., Rizk, N. P., & Rusch, V. W. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.07.080 · Cited by 269
Factors Associated With Decisions to Undergo Surgery Among Patients With Newly Diagnosed Early-Stage Lung Cancer
Cykert, S. (2010) · JAMA · doi:10.1001/jama.2010.793 · Cited by 272
A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States
Insinga, R. P., Liaw, K., Johnson, L., & Madeleine, M. M. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2922 · Cited by 268
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
Cappuzzo, F., Finocchiaro, G., Rossi, E., Jänne, P. A., Carnaghi, C., Calandri, C., Bencardino, K., Ligorio, C., Ciardiello, F., Pressiani, T., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm492 · Cited by 267
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Bierie, B., Tada, M., Mohri, D., Miyabayashi, K., Asaoka, Y., Maeda, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42754 · Cited by 256
Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites
Zini, A., Czerninski, R., & Sgan‐Cohen, H. D. (2010) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2009.00845.x · Cited by 265
Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program
Lachiewicz, A. M., Berwick, M., Wiggins, C. L., & Thomas, N. E. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.4.515 · Cited by 266
Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment
Hallek, M. J. (2015) · American Journal of Hematology · doi:10.1002/ajh.23979 · Cited by 275
An updated catalog of prostate cancer predictive tools
Shariat, S. F., Karakiewicz, P. I., Roehrborn, C. G., & Kattan, M. W. (2008) · Cancer · doi:10.1002/cncr.23908 · Cited by 264
Mitochondrial DNA Content: Its Genetic Heritability and Association With Renal Cell Carcinoma
Xing, J., Chen, M., Wood, C. G., Lin, J., Spitz, M. R., Ma, J., Amos, C. I., Shields, P. G., Benowitz, N. L., Gu, J. H., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn213 · Cited by 263
Imaging in staging of malignant lymphoma: a systematic review
Kwee, T. C., Kwee, R. M., & Nievelstein, R. A. J. (2007) · Blood · doi:10.1182/blood-2007-07-101899 · Cited by 262
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer
Arndt, G. M., Dossey, L., Cullen, L. M., Lai, A. K. W., Druker, R., Eisbacher, M., Zhang, C., Tran, N., Fan, H., Retzlaff, K., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-374 · Cited by 261
Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older
Lane, B. R., Abouassaly, R., Gao, T., Weight, C., Hernández, A. V., Larson, B. T., Kaouk, J. H., Gill, I. S., & Campbell, S. C. (2010) · Cancer · doi:10.1002/cncr.25184 · Cited by 260
The Effect of Patient Navigation on Time to Diagnosis, Anxiety, and Satisfaction in Urban Minority Women with Abnormal Mammograms: A Randomized Controlled Trial
Ferrante, J. M., Chen, P.-H., & Kim, S. H. (2007) · Journal of Urban Health · doi:10.1007/s11524-007-9228-9 · Cited by 260
Anti–Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis
Egberts, J. D., Cloosters, V., Noack, A., Schniewind, B., Thon, L., Klose, S., Kettler, B., von Forstner, C., Kneitz, C., Tepel, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5704 · Cited by 259
Implementing a Survivorship Care Plan for Patients With Breast Cancer
Ganz, P. A., & Hahn, E. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2851 · Cited by 266
Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C.
Adelstein, D. J., Ridge, J. A., Gillison, M. L., Chaturvedi, A. K., DʼSouza, G., Gravitt, P. E., Westra, W. H., Psyrri, A. K., Kast, W. M., Koutsky, L. A., et al. (2009) · Head & Neck · doi:10.1002/hed.21269 · Cited by 259
Prevalence of Adenomas and Colorectal Cancer in Average Risk Individuals: A Systematic Review and Meta-analysis
Heitman, S. J., Ronksley, P. E., Hilsden, R. J., Manns, B., Rostom, A., & Hemmelgarn, B. R. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.032 · Cited by 258
Retinoic Acid Receptor Antagonists Inhibit miR-10a Expression and Block Metastatic Behavior of Pancreatic Cancer
Weiß, F. U., Marques, I. J., Woltering, J. M., Vlecken, D. H. W., Aghdassi, A. A., Partecke, L. I., Heidecke, C.-D., Lerch, M. M., & Bagowski, C. P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.065 · Cited by 258
The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer
Poley, J. W., Kluijt, I., Gouma, D. J., Harinck, F., Wagner, A., Aalfs, C., van Eijck, C. H. J., Cats, A., Kuipers, E. J., Nio, Y., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.276 · Cited by 257
Pathophysiology, Clinical Presentation, and Management of Colon Cancer
Cappell, M. S. (2008) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.12.002 · Cited by 257
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines
Crawford, M., Brawner, E. J., Batte, K., Yu, L., Hunter, M. G., Otterson, G. A., Nuovo, G. J., Marsh, C. B., & Nana-Sinkam, S. P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.090 · Cited by 256
Three-gene prognostic classifier for early-stage non small-cell lung cancer
Lau, S. K., Boutros, P. C., Pintilie, M., Blackhall, F. H., Zhu, C.-Q., Strumpf, D., Johnston, M. R., Darling, G., Keshavjee, S., Waddell, T. K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0352 · Cited by 255
Pancreatogenic Diabetes: Special Considerations for Management
Cui, Y., & Andersen, D. K. (2011) · Pancreatology · doi:10.1159/000329188 · Cited by 256
The MAPK pathway in melanoma
Fecher, L. A., Amaravadi, R. K., & Flaherty, K. T. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f5271c · Cited by 257
Head and neck cancer
Cognetti, D. M., Weber, R. S., & Lai, S. Y. (2008) · Cancer · doi:10.1002/cncr.23654 · Cited by 253
Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer
Schellenberg, D. D., Kim, J., Christman-Skieller, C., Chun, C. L., Columbo, L. A., Ford, J. M., Fisher, G. A., Kunz, P. L., Dam, J. V., Quon, A. S. W., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.006 · Cited by 253
Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review
Terasawa, T., Lau, J., Bardet, S., Couturier, O., Hotta, T., Hutchings, M., Nihashi, T., & Nagai, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0861 · Cited by 252
Obesity and Prostate Cancer: Epidemiology and Clinical Implications
Buschemeyer, W. C., & Freedland, S. J. (2007) · European Urology · doi:10.1016/j.eururo.2007.04.069 · Cited by 253
Molecular Recognition of Small‐Cell Lung Cancer Cells Using Aptamers
Chen, H. W., Medley, C. D., Sefah, K., Shangguan, D., Tang, Z., Meng, L. H., Smith, J. E., & Tan, W. (2008) · ChemMedChem · doi:10.1002/cmdc.200800030 · Cited by 250
EUROGIN 2011 roadmap on prevention and treatment of HPV‐related disease
Arbyn, M., de Sanjosé, S., Saraiya, M., Sideri, M. G., Palefsky, J. M., Lacey, C. J., Gillison, M. L., Bruni, L., Ronco, G., Wentzensen, N., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27650 · Cited by 254
Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group
McDermott, D. F., Sosman, J. A., Gonzalez, R. C., Hodi, F. S., Linette, G. P., Richards, J. M., Jakub, J. W., Beeram, M., Tarantolo, S., Agarwala, S. S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8288 · Cited by 247
Lymphadenectomy in the Surgical Management of Penile Cancer
Protzel, C., Alcaraz, A., Horenblas, S., Giorgio Pizzocaro, A., Zlotta, A. R., & Hakenberg, O. W. (2009) · European Urology · doi:10.1016/j.eururo.2009.02.021 · Cited by 248
Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model
Marques, I. J., Weiß, F. U., Vlecken, D. H. W., Nitsche, C. J., Bakkers, J., Lagendijk, A. K., Partecke, L. I., Heidecke, C.-D., Lerch, M. M., & Bagowski, C. P. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-128 · Cited by 247
Impact of aging on the biology of breast cancer
Benz, C. C. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.09.001 · Cited by 246
Diagnosis and management of lipomatous tumors
Dalal, K. M., Antonescu, C. R., & Singer, S. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.20975 · Cited by 246
Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone‐refractory prostate cancer
Nelson, J. B., Love, W., Chin, J. L., Fred Saad, C., Schulman, C. C., Sleep, D. J., Qian, J. X., Steinberg, J., Carducci, M. A., & for the Atrasentan Phase 3 Study Group (2008) · Cancer · doi:10.1002/cncr.23864 · Cited by 245
miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer
Tsuchida, A., Ohno, S., Wu, W., Borjigin, N., Fujita, K., Aoki, T., Ueda, S., Takanashi, M., & Kuroda, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02081.x · Cited by 245
Transforming growth factor-β and the hallmarks of cancer
Tian, M., Neil, J. R., & Schiemann, W. P. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.015 · Cited by 254
Down-regulation of Forkhead Box M1 Transcription Factor Leads to the Inhibition of Invasion and Angiogenesis of Pancreatic Cancer Cells
Wang, Z. P., Banerjee, S., Kong, D., Li, Y., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1265 · Cited by 245
Retracted
Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience
Attenello, F. J., Mukherjee, D. R., Datoo, G., McGirt, M. J., Bohan, E. M., WEINGART, J. D., Olivi, A., Quiñones‐Hinojosa, A., & Brem, H. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0048-2 · Cited by 245
Fibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma
Cohen, S. J., Alpaugh, R. K., Palazzo, I., Meropol, N. J., Rogatko, A., Xu, Z., Hoffman, J. P., Weiner, L. M., & Cheng, J. D. (2008) · Pancreas · doi:10.1097/mpa.0b013e31816618ce · Cited by 244
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
Vahdat, L. T., Pruitt, B. T., Fabian, C. J., Rivera, R., Smith, D. A. B., Tan-Chiu, E., Wright, J., Tan, A. R., Dacosta, N. A., Chuang, E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7618 · Cited by 244
Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis
Tomida, S., Takeuchi, T., Shimada, Y., Arima, C., Matsuo, K., Mitsudomi, T., Yatabe, Y., & Takahashi, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.7053 · Cited by 243
Renal Cell Carcinoma: Diagnosis, Staging, and Surveillance
Ng, C. S., Wood, C. G., Silverman, P. M., Tannir, N. M., Tamboli, P., & Sandler, C. M. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3568 · Cited by 243
The anatomic location of pancreatic cancer is a prognostic factor for survival
Artinyan, A., Soriano, P. A., Prendergast, C., Low, T., Ellenhorn, J. D. I., & Kim, J. (2008) · HPB · doi:10.1080/13651820802291233 · Cited by 241
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
Kheir, T. B., Futoma-Kazmierczak, E., Skanderup, A. J., Krogh, A., Bardram, L., Hother, C. E., Grønbæk, K., Federspiel, B., Lund, A. H., & Friis-Hansen, L. J. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-29 · Cited by 247
Survival Outcomes in Advanced Laryngeal Cancer
Megwalu, U. C., & Sikora, A. G. (2014) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2014.1671 · Cited by 240
Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines
Smith, F. O., Downey, S. G., Klapper, J. A., Yang, J. C.-H., Sherry, R. M., Royal, R. E., Kammula, U. S., Hughes, M. S., Restifo, N. P., Levy, C. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0116 · Cited by 239
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics
Farasat, S., Yu, S. S., Neel, V., Nehal, K. S., Lardaro, T., Mihm, M. C., Byrd, D. R., Balch, C. M., Califano, J. A., Chuang, A., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.08.033 · Cited by 241
The disparity of cervical cancer in diverse populations
Downs, L. S., Smith, J. S., Scarinci, I. C., Flowers, L., & Parham, G. P. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.003 · Cited by 236
Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): From microscopic measurements to macroscopic predictions of clinical progression
Macklin, P., Edgerton, M. E., Thompson, A. M., & Vittorio Cristini, C. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.02.002 · Cited by 236
Granulocyte Macrophage Colony-Stimulating Factor–Secreting Allogeneic Cellular Immunotherapy for Hormone-Refractory Prostate Cancer
Small, E. J., Sacks, N., Nemunaitis, J. J., Urba, W. J., Dula, E., Centeno, A. S., Nelson, W. G., Ando, D. G., Howard, C., Borellini, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2937 · Cited by 235
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
Santini, D., Loupakis, F., Vincenzi, B., Floriani, I., Stasi, I., Canestrari, E., Rulli, E., Maltese, P. E., Andreoni, F., Masi, G., et al. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0181 · Cited by 234
How Good is Endoscopic Ultrasound in Differentiating Various T Stages of Rectal Cancer? Meta-Analysis and Systematic Review
Puli, S. R., Bechtold, M. L., Reddy, J. B., Choudhary, A., Antillon, M. R., & Brugge, W. R. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0231-5 · Cited by 234
Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model
Park, S. I., Zhang, J., Phillips, K. A., Araujo, J. C., Najjar, A. M., Volgin, A. Y., Gelovani, J. G., Kim, S., Wang, Z., & Gallick, G. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2997 · Cited by 233
Molecular Basis of Nuclear Factor-κB Activation by Astrocyte Elevated Gene-1
Sarkar, D., Park, E. S., Emdad, L., Lee, S., Su, Z.-Z., & Fisher, P. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6164 · Cited by 232
Treatment of Localised Renal Cell Carcinoma
Poppel, H. V., Becker, F. O., Cadeddu, J. A., Gill, I. S., Janetschek, G., Jewett, M. A. S., Laguna, M. P., Marberger, M., Montorsi, F., Polascik, T. J., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.040 · Cited by 232
Non‐solid oncogenes in solid tumors: EML4–ALK fusion genes in lung cancer
Mano, H. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00972.x · Cited by 232
Glutathione Peroxidase 3, Deleted or Methylated in Prostate Cancer, Suppresses Prostate Cancer Growth and Metastasis
Yu, Y. P., Yu, G., Tseng, G. C., Cieply, K. M., Nelson, J. B., DeFrances, M. C., Zarnegar, R., Michalopoulos, G. K., & Luo, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0648 · Cited by 231
Cohort Profile: The Adventist Health Study-2 (AHS-2)
Butler, T. L., Fraser, G. E., Beeson, W. L., Knutsen, S. F., Herring, R. P., Chan, J., Sabaté, J., Montgomery, S., Haddad, E. H., Preston‐Martin, S., et al. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym165 · Cited by 231
Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer
Glöckner, S. C., Dhir, M., Yi, J. M., McGarvey, K. M., Neste, L. V., Louwagie, J., Chan, T. A.-T., Kleeberger, W., de Bruı̈ne, A. P., Smits, K. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0142 · Cited by 232
Utilization and Outcomes of Minimally Invasive Radical Prostatectomy
Hu, J. C., Wang, Q., Pashos, C. L., Lipsitz, S. R., & Keating, N. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.4528 · Cited by 230
Estrogen Receptors as Therapeutic Targets in Breast Cancer
Ariazi, E. A., & Jordan, V. C. (2008) · Methods and principles in medicinal chemistry · doi:10.1002/9783527623297.ch5 · Cited by 230
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
Pignata, S., Scambia, G., Ferrandina, G., Savarese, A., Sorio, R., Breda, E., Gebbia, V., Musso, P., Frigerio, L., Del Medico, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.8566 · Cited by 229
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
Han, B., Mehra, R., Lonigro, R. J., Wang, L., Suleman, K., Menon, A., Palanisamy, N., Tomlins, S. A., Chinnaiyan, A. M., & Shah, R. B. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.69 · Cited by 228
Breath biomarkers for lung cancer detection and assessment of smoking related effects — confounding variables, influence of normalization and statistical algorithms
Kischkel, S., Miekisch, W., Sawacki, A., Straker, E. M., Trefz, P., Amann, A., & Schubert, J. K. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.06.005 · Cited by 227
The chemoradiation paradigm in head and neck cancer
Seiwert, T. Y., Salama, J. K., & Vokes, E. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0750 · Cited by 227
Labeled versus Unlabeled Discrete Choice Experiments in Health Economics: An Application to Colorectal Cancer Screening
de Bekker-Grob, E. W., Hol, L., Donkers, B., van Dam, L., Habbema, J. D., van Leerdam, M. E., Kuipers, E. J., Essink‐Bot, M., & Steyerberg, E. W. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00670.x · Cited by 227
Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study
Natale, R. B., Bodkin, D., Govindan, R., Sleckman, B. G., Rizvi, N. A., Capó, A., Germonpré, P. R., Eberhardt, W., Stockman, P. K., Kennedy, S. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6015 · Cited by 226
Plectin-1 as a Novel Biomarker for Pancreatic Cancer
Bausch, D., Thomas, S., Mino-Kenudson, M. A., Fernández-del, C. C., Bauer, T. W., Williams, M., Warshaw, A. L., Thayer, S. P., & Kelly, K. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0999 · Cited by 226
Identification of a MicroRNA Panel for Clear-cell Kidney Cancer
Juan, D., Alexe, G., Antes, T. J., Liu, H., Madabhushi, A., DeLisi, C., Ganesan, S., Bhanot, G. V., & Liou, L. S. (2009) · Urology · doi:10.1016/j.urology.2009.10.033 · Cited by 225
A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Modesitt, S. C., Sill, M. W., Hoffman, J. S., & Bender, D. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.009 · Cited by 225
Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data
Freedland, S. J., & Platz, E. A. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm006 · Cited by 226
Challenges of Cancer Biomarker Profiling
Bensalah, K., Montorsi, F., & Shariat, S. F. (2007) · European Urology · doi:10.1016/j.eururo.2007.09.036 · Cited by 228
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis
Siddiqui, I. A., Malik, A., Adhami, V. M., Asim, M., Hafeez, B. B., Sarfaraz, S., & Mukhtar, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210840 · Cited by 223

Authors: Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J.
Affiliations: American Cancer Society (US)
Centers for Disease Control and Prevention (US)
ORCID: Jemal, A.
Siegel, R.
Ward, E.
Xu, J.
Venue: CA: A Cancer Journal for Clinicians
Publisher: Wiley
Published: 2007-01-01
Volume: 57
Issue: 1
Pages: 43-66
ISSN: 0007-9235 (ISSN-L)
DOI: 10.3322/canjclin.57.1.43
OpenAlex: W1965734230
Cited by: 7,439
References: 10
Citations by year: 2026: 18 · 2025: 34 · 2024: 74 · 2023: 104 · 2022: 93 · 2021: 125 · 2020: 135 · 2019: 100 · 2018: 117 · 2017: 182 · 2016: 196 · 2015: 217 · 2014: 333 · 2013: 334 · 2012: 419
FWCI: 749.63
Type: journal article
Language: en
Open access: gold
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3165 d)
Locations: CA A Cancer Journal for Clinicians (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords: cancer incidence, cancer mortality, cancer survival, cancer projections, age-standardized incidence rate, sex differences in cancer, racial and ethnic disparities, geographic variation in cancer, cancer control
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Cause of Death, Child, Child, Preschool, Female, Geography, Humans, Infant, Infant, Newborn, Male, Middle Aged, Neoplasms, Population Surveillance, United States, Models, Statistical, Incidence, Survival Analysis, Age Distribution, Sex Distribution, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer Statistics, 2007

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks